Parkinson's Disease
Conditions
Interventions
Group 1:NBP, NBP 200 mg three times daily for 24 weeks
Group 2:no
Sponsors
Department of Neurology, Anhui Provincial Hospital Affiliated to the Chinese Academy of Sciences
Eligibility
Sex/Gender
All
Age
49 Years to 79 Years
Inclusion criteria
Inclusion criteria: Patients were eligible for participation in the study if they 1. had idiopathic PD confirmed by a movement disorders specialist, according to the Parkinson's Disease Society Brain Bank criteria [8]; 2. had been receiving a stable medication regimen for a duration of = 6 weeks or were early PD patients who had no prior medication treatment and were going for their first consultation; 3. Aged 40 and 80 years; 4. had a family member or friend who was willing to participate.
Exclusion criteria
Exclusion criteria: Any factor that may have precluded completion of neuropsychological testing; clinically significant gastrointestinal, hepatic, renal, respiratory, or cardiovascular system disease; infection; alcoholism; drug addiction; or known hypersensitivity to celery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UPDRS;MMSE;ESS;PSQI;FSS;Age;Age;HRSD;HAMA;PDQ-39;PDQ-39; | — |
Secondary
| Measure | Time frame |
|---|---|
| H-Y staging;Levodopa equivalent dose;Duration of disease; | — |
Countries
China
Contacts
Public ContactYuhua Chen
Department of Neurology, Anhui Provincial Hospital Affiliated to the Chinese Academy of Sciences
Outcome results
None listed